HARTWELL J M LIMITED PARTNERSHIP - PORTOLA PHARMACEUTICALS INC ownership

PORTOLA PHARMACEUTICALS INC's ticker is PTLA and the CUSIP is 737010108. A total of 217 filers reported holding PORTOLA PHARMACEUTICALS INC in Q4 2017. The put-call ratio across all filers is 2.74 and the average weighting 0.3%.

Quarter-by-quarter ownership
HARTWELL J M LIMITED PARTNERSHIP ownership history of PORTOLA PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2019$322,000
-80.7%
12,000
-75.1%
0.06%
-81.2%
Q1 2019$1,671,000
+149.8%
48,150
+40.6%
0.30%
+118.7%
Q4 2018$669,000
-10.8%
34,250
+21.7%
0.14%
+6.9%
Q3 2018$750,000
-36.1%
28,150
-9.3%
0.13%
-38.7%
Q2 2018$1,173,000
+18.8%
31,050
+2.7%
0.21%
+14.6%
Q1 2018$987,000
-30.4%
30,225
+3.8%
0.18%
-30.5%
Q4 2017$1,418,000
-26.0%
29,125
-17.8%
0.27%
-29.1%
Q3 2017$1,915,000
+139.4%
35,450
+148.8%
0.38%
+125.9%
Q2 2017$800,000
+99.0%
14,250
+39.0%
0.17%
+88.6%
Q1 2017$402,00010,2500.09%
Other shareholders
PORTOLA PHARMACEUTICALS INC shareholders Q4 2017
NameSharesValueWeighting ↓
Fernwood Investment Management, LLC 232,952$5,498,0005.39%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 3,673,727$86,700,0003.41%
Redmile Group, LLC 1,466,537$34,610,0003.31%
SECTORAL ASSET MANAGEMENT INC 1,229,382$29,013,0003.00%
HARVEY CAPITAL MANAGEMENT INC 206,530$4,874,0002.44%
Marcus Capital, LLC 75,150$1,774,0001.87%
Cormorant Asset Management, LP 396,000$9,346,0001.32%
Rail-Splitter Capital Management, LLC 221,414$5,225,0001.25%
Temasek Holdings (Private) Ltd 6,583,568$155,372,0001.21%
EMERALD MUTUAL FUND ADVISERS TRUST 636,526$15,022,0000.84%
View complete list of PORTOLA PHARMACEUTICALS INC shareholders